Case-Control Studies Are Not Familial Studies

Neuron

Volumn 92, Issue 2, 2016, Pages 339-341

  Wang, Zhe ^a   Sadovnick, A Dessa ^a   Traboulsee, Anthony L ^a   Ross, Jay P ^a   Bernales, Cecily Q ^a   Encarnacion, Mary ^a   Yee, Irene M ^a   de Lemos, Madonna ^a   Greenwood, Talitha ^a   Lee, Joshua D ^a   Wright, Galen ^a   Ross, Colin J ^a   Zhang, Si ^a   Song, Weihong ^a   Vilariño Güell, Carles ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE CONTROL STUDY; FAMILIAL DISEASE; FAMILY; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; HUMAN; MEASUREMENT ACCURACY; MEDICAL LITERATURE; MULTIPLE SCLEROSIS; NR1H3 GENE; PRIORITY JOURNAL; PUBLICATION; PUBLISHING; ALLELE; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS;

ALLELES; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MULTIPLE SCLEROSIS;

EID: 84992345415     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2016.09.053     Document Type: Article

References (30)

1. Armstrong, R.A., When to use the Bonferroni correction. Ophthalmic Physiol. Opt. 34 (2014), 502–508.
2. Beecham, A.H., Patsopoulos, N.A., Xifara, D.K., Davis, M.F., Kemppinen, A., Cotsapas, C., Shah, T.S., Spencer, C., Booth, D., Goris, A., et al. International Multiple Sclerosis Genetics Consortium (IMSGC) Wellcome Trust Case Control Consortium 2 (WTCCC2), International IBD Genetics Consortium (IIBDGC). Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat. Genet. 45 (2013), 1353–1360.
3. Clark, L.N., Wang, Y., Karlins, E., Saito, L., Mejia-Santana, H., Harris, J., Louis, E.D., Cote, L.J., Andrews, H., Fahn, S., et al. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology 67 (2006), 1786–1791.
4. Dunn, O.J., Multiple comparisons among means. J. Am. Stat. Assoc. 56 (1961), 52–64.
5. Hernán, M.A., Clayton, D., Keiding, N., The Simpson's paradox unraveled. Int. J. Epidemiol. 40 (2011), 780–785.
6. Hor, H., Francescatto, L., Bartesaghi, L., Ortega-Cubero, S., Kousi, M., Lorenzo-Betancor, O., Jiménez-Jiménez, F.J., Gironell, A., Clarimón, J., Drechsel, O., et al. Missense mutations in TENM4, a regulator of axon guidance and central myelination, cause essential tremor. Hum. Mol. Genet. 24 (2015), 5677–5686.
7. Huang, Y., Chen, Z., Inflammatory bowel disease related innate immunity and adaptive immunity. Am. J. Transl. Res. 8 (2016), 2490–2497.
8. Johnson, J.O., Mandrioli, J., Benatar, M., Abramzon, Y., Van Deerlin, V.M., Trojanowski, J.Q., Gibbs, J.R., Brunetti, M., Gronka, S., Wuu, J., et al., ITALSGEN Consortium. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 68 (2010), 857–864.
9. Johnson, J.O., Pioro, E.P., Boehringer, A., Chia, R., Feit, H., Renton, A.E., Pliner, H.A., Abramzon, Y., Marangi, G., Winborn, B.J., et al., ITALSGEN Consortium. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat. Neurosci. 17 (2014), 664–666.
10. Ku, C.S., Naidoo, N., Pawitan, Y., Revisiting Mendelian disorders through exome sequencing. Hum. Genet. 129 (2011), 351–370.
11. Lek, M., Karczewski, K.J., Minikel, E.V., Samocha, K.E., Banks, E., Fennell, T., O'Donnell-Luria, A.H., Ware, J.S., Hill, A.J., Cummings, B.B., et al., Exome Aggregation Consortium. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536 (2016), 285–291.
12. Minikel, E.V., MacArthur, D.G., Publicly available data provide evidence against NR1H3 R415Q causing multiple sclerosis. Neuron 92 (2016), 336–338 this issue.
13. Ng, S.B., Bigham, A.W., Buckingham, K.J., Hannibal, M.C., McMillin, M.J., Gildersleeve, H.I., Beck, A.E., Tabor, H.K., Cooper, G.M., Mefford, H.C., et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat. Genet. 42 (2010), 790–793.
14. Nyholt, D.R., All LODs are not created equal. Am. J. Hum. Genet. 67 (2000), 282–288.
15. Ott, J., Computer-simulation methods in human linkage analysis. Proc. Natl. Acad. Sci. USA 86 (1989), 4175–4178.
16. Parikh, M., Patel, K., Soni, S., Gandhi, T., Liver X receptor: a cardinal target for atherosclerosis and beyond. J. Atheroscler. Thromb. 21 (2014), 519–531.
17. Pickup, J.C., Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27 (2004), 813–823.
18. Poli, G., Biasi, F., Leonarduzzi, G., Oxysterols in the pathogenesis of major chronic diseases. Redox Biol. 1 (2013), 125–130.
19. Purcell, S., Cherny, S.S., Sham, P.C., Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19 (2003), 149–150.
20. Quadri, M., Fang, M., Picillo, M., Olgiati, S., Breedveld, G.J., Graafland, J., Wu, B., Xu, F., Erro, R., Amboni, M., et al., International Parkinsonism Genetics Network. Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism. Hum. Mutat. 34 (2013), 1208–1215.
21. Rabbani, B., Mahdieh, N., Hosomichi, K., Nakaoka, H., Inoue, I., Next-generation sequencing: impact of exome sequencing in characterizing Mendelian disorders. J. Hum. Genet. 57 (2012), 621–632.
22. Sambuughin, N., Goldfarb, L.G., Sivtseva, T.M., Davydova, T.K., Vladimirtsev, V.A., Osakovskiy, V.L., Danilova, A.P., Nikitina, R.S., Ylakhova, A.N., Diachkovskaya, M.P., et al. Adult-onset autosomal dominant spastic paraplegia linked to a GTPase-effector domain mutation of dynamin 2. BMC Neurol., 15, 2015, 223.
23. Smith, B.N., Vance, C., Scotter, E.L., Troakes, C., Wong, C.H., Topp, S., Maekawa, S., King, A., Mitchell, J.C., Lund, K., et al. Novel mutations support a role for Profilin 1 in the pathogenesis of ALS. Neurobiol. Aging 36 (2015), 1602.e17–1602.e27.
24. Stranneheim, H., Wedell, A., Exome and genome sequencing: a revolution for the discovery and diagnosis of monogenic disorders. J. Intern. Med. 279 (2016), 3–15.
25. Tall, A.R., Yvan-Charvet, L., Cholesterol, inflammation and innate immunity. Nat. Rev. Immunol. 15 (2015), 104–116.
26. The International Multiple Sclerosis Genetics Consortium. NR1H3 p.Arg415Gln is not associated to multiple sclerosis risk. Neuron 92 (2016), 333–335 this issue.
27. Vilariño-Güell, C., Wider, C., Ross, O.A., Dachsel, J.C., Kachergus, J.M., Lincoln, S.J., Soto-Ortolaza, A.I., Cobb, S.A., Wilhoite, G.J., Bacon, J.A., et al. VPS35 mutations in Parkinson disease. Am. J. Hum. Genet. 89 (2011), 162–167.
28. Vilariño-Güell, C., Rajput, A., Milnerwood, A.J., Shah, B., Szu-Tu, C., Trinh, J., Yu, I., Encarnacion, M., Munsie, L.N., Tapia, L., et al. DNAJC13 mutations in Parkinson disease. Hum. Mol. Genet. 23 (2014), 1794–1801.
29. Wang, Z., Sadovnick, A.D., Traboulsee, A.L., Ross, J.P., Bernales, C.Q., Encarnacion, M., Yee, I.M., de Lemos, M., Greenwood, T., Lee, J.D., et al. Nuclear receptor NR1H3 in familial multiple sclerosis. Neuron 90 (2016), 948–954.
30. Yang, J., Ferreira, T., Morris, A.P., Medland, S.E., Madden, P.A., Heath, A.C., Martin, N.G., Montgomery, G.W., Weedon, M.N., Loos, R.J., et al. Genetic Investigation of ANthropometric Traits (GIANT) Consortium, DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet. 44 (2012), 369–375, S1–S3.